Extracorporeal low-density lipoprotein (LDL) apheresis is an established and highly effective therapy for the patients with familial hypercholesterolemia (FH) not adequately responding to diet and drug therapy alone. This study was designed to measure the effect of lipid apheresis on oxidant and antioxidant status in a patient with FH. The levels of plasma lipid peroxidation were determined as thiobarbituric acid-reactive substances. The activities of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were established in one subject with FH before and after lipid apheresis.
The pre- and post lipid apheresis procedures witness a significant decrease in oxidative stress (p<0.05) but the erythrocyte levels of CAT, SOD and GPx were unchanged.
YamamotoA., Harada-ShibaM., KawaguchiA., TsushimaM.Apheresis technology for prevention and regression of atherosclerosis. Ther Apher2001; 5: 221–5.
2.
KogaN.Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia. Ther Apher2001; 5: 244–51.
3.
BlahaM.Extracorporeal LDL-cholesterol in the treatment severe familial hypercholesterolemia. Acta Med2003; 46: 3–7.
Bonnefont-RousselotD., BastardJ.P., JaudonM.C., DelattreJ.Consequences of the diabetic atatus on the oxidant/antioxidant balance. Diabetes Metab2000; 26: 163–76.
6.
WasowiczW., NeveJ., PeretzA.Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem1993; 39: 2533–6.
7.
MisraH.P., FridovichI.The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem1973; 247: 3170–5.
8.
AebiH.E.Catalase of enzymatic analysis. In: BergmeyerH.U., ed. Volume III enzymes 1. Oxidoreductases, transferases.Weinheim: VCH Verlagsgesellschaft, 1987; 273–85.
9.
BaricchiR., PizzalaR., CacciavillaniG., RivasiP., TomasiA.The effect of selective low-density lipoprotein apheresis on plasma lipoperoxides and antioxidant vitamins in familial hypercholesterolemic patients. Ther Apher1998; 2: 218–23.
BambauerR.Low-density lipoprotein apheresis: Clinical results with different methods. Artif Organs2002; 26: 133–9.
12.
KobayashiJ., KatsubeS., ShimodaM., FuruhashiK., KitanoS.Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde modify low-density lipoprotein concentration in Japanese hypercholesterolemic subjects. Clin Chim Acta2002; 321: 107–12.
13.
FadulJ.E., VessbyB., WikstromB., DanielsonB.G.Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: A 4 year follow-up study. Artif Organs1997; 21: 364–8.
14.
StefanuttiC., Di GiacomoS., VivenzioA., IsacchiG.C., MasellaR.Acute and long-term effects of low-density lipoprotein (LDL)- apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolamia. Clin Sci2001; 100: 191–8.
15.
HulhteJ., WikstrandJ., LidellA., WendelhagI., HanssonG.K.Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol1998; 18: 1203–11.
16.
HusseinO., FrydmanG., FrimH., AviramM.Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholesterolemic children. Pathophysiology2001; 8: 21–8.
17.
LubranoV., VassalleC., BlandizziC., Del TaccaM., PalomboC.The effect of lipoprotein on endothelial nitric oxide synthase modulated by lipoperoxides. Eur J Clin Invest2003; 33: 117–25.
18.
DelattreJ., LepageS., JaudonM.C., BruckertE., AssogbaU.The plasma antioxidant status and trace elements in patients with familial hypercholesterolemia treated with LDL-apheresis. Ann Pharm Fr1998; 56: 18–25.
